FDA
approval
· 2023-11-22
FDA Approved: DIAZEPAM — Supplemental Application (Sunrise Pharmaceutical, Inc.)
Summary
The FDA approved a supplemental application for Diazepam submitted by Sunrise Pharmaceutical, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DIAZEPAM (DIAZEPAM)